![Kevin Tang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Tang
Directeur Général chez
KEZAR LIFE SCIENCES, INC.
Profil
Kevin C.
Tang is the founder of Tang Capital Management LLC, founded in 2002, serving as Manager.
Mr. Tang was the founder of Ardea Biosciences, Inc., founded in 1994, serving as Independent Director from 2011 to 2012.
Mr. Tang was the founder of Concentra Biosciences LLC, founded in 2023, serving as Chairman & Chief Executive Officer.
Current jobs include Chief Executive Officer at Allakos, Inc. starting in 2025; Chief Executive Officer & Director at Kezar Life Sciences, Inc. starting in 2026; Chief Executive Officer & Director at Jounce Therapeutics, Inc.; Chief Executive Officer & Executive Director at Elevation Oncology, Inc. starting in 2025; Chief Executive Officer & Director at iTeos Therapeutics, Inc. starting in 2025; Chairman & Chief Executive Officer at Aurinia Pharmaceuticals, Inc. starting in 2024; and Director at Kronos Bio, Inc. starting in 2025.
Former jobs include Chairman & Chief Executive Officer at Odonate, Inc. from 2013 to 2022; Chief Executive Officer & Director at Theseus Pharmaceuticals, Inc.; Chairman at Heron Therapeutics, Inc. from 2012 to 2020; Chairman at La Jolla Pharmaceutical Co. from 2014 to 2022; Director at Trimeris, Inc. from 2001 to 2008; Director at Penwest Pharmaceuticals Co. in 2010; Managing Director at Cash Reserve Fund, Inc. from 1993 to 2001; Director at ACLARA Biosciences, Inc.; Director at IntraBiotics Pharmaceuticals, Inc.; Managing Director & Head-Life Sciences Research at Deutsche Bank Alex.
Brown, Inc. from 1993 to 2001; Director at RadPharm, Inc.; Director at Prospect Therapeutics, Inc.; Director at Tetraphase Pharmaceuticals, Inc.; and Head of Life Sciences Research Group at Deutsche Bank Securities, Inc. from 1993 to 2001.
Education includes an undergraduate degree from Duke University, conferred in 1989.
Dernières actualités sur Kevin Tang
Postes actifs de Kevin Tang
| Sociétés | Poste | Début |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Directeur Général | - |
| AURINIA PHARMACEUTICALS INC. | Directeur Général | 23/03/2026 |
| ALLAKOS INC. | Directeur Général | 15/05/2025 |
| KRONOS BIO, INC. | Directeur/Membre du Conseil | 20/06/2025 |
| ELEN ONCO | Directeur Général | 23/07/2025 |
| ITEOS THERAPEUTICS, INC. | Directeur Général | 28/08/2025 |
| KEZAR LIFE SCIENCES, INC. | Directeur Général | 11/05/2026 |
Tang Capital Management LLC
 Tang Capital Management LLC Investment ManagersFinance Tang Capital focuses on investments in small-cap US companies in the life sciences sector. | Directeur Général | 01/08/2002 |
Anciens postes connus de Kevin Tang
| Sociétés | Poste | Fin |
|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Président | 22/08/2022 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Kevin Tang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Health Technology |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Cash Reserve Fund, Inc.
 Cash Reserve Fund, Inc. Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
ACLARA Biosciences, Inc.
 ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology Discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic and oncologic diseases | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Health Technology |
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital focuses on investments in small-cap US companies in the life sciences sector. | Finance |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deutsche Bank Alex. Brown, Inc.
 Deutsche Bank Alex. Brown, Inc. Financial ConglomeratesFinance Provides wealth management services | Finance |
RadPharm, Inc.
 RadPharm, Inc. Medical/Nursing ServicesHealth Services Provides oncology and medical imaging review services | Health Services |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Prospect Therapeutics, Inc.
 Prospect Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals to treat variety of cancers | Health Technology |
Allakos, Inc.
 Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases | Health Technology |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Kezar Life Sciences, Inc.
 Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Odonate, Inc.
 Odonate, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer treatment | Health Technology |
Kronos Bio, Inc.
 Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients | Health Technology |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Elevation Oncology, Inc.
 Elevation Oncology, Inc. BiotechnologyHealth Technology Develops elevating precision medicines for cancer treatment | Health Technology |
Concentra Biosciences LLC
 Concentra Biosciences LLC Finance/Rental/LeasingFinance Operates as a special purpose company for strategic biotech acquisition | Finance |
